The National Agency of Drug and Food Control of Indonesia (Badan Pengawas Obat dan Makanan) has approved a prebiotic claim for the chicory root fibres, inulin and oligofructose. They are now the first and only ingredients recognised as prebiotics in the country. This approval was made possible thanks to BENEO’s continuous research and its effort in communicating the prebiotic effect of inulin and oligofructose to the local authorities.
The claim is approved under the milk powder category for the general population, referring to healthy people above three years old, including teenagers, adults, and the elderly. The minimum required dose is 4.5g/L on a ready-to-drink basis of inulin and oligofructose, in 30:70 ratio. By incorporating BENEO’s chicory foot fibre into milk powder applications, manufacturers can now meet consumers’ growing interest in products that promote the gut microbiome and digestive health.
This is a big step forward for Indonesia – the largest consumer market in South East Asia1 – where two-thirds of consumers associate prebiotics with a healthy gut2. More than half of Indonesians are also seeking out food and drink products that can improve digestive health. In fact, the top two health concerns among local consumers are immunity and digestive health3 – both of which are closely linked to the gut environment.
“We are pleased that the chicory root fibres inulin and oligofructose are the first prebiotics to be recognised by the Indonesia National Agency of Drug and Food Control. This ensures that BENEO’s prebiotic chicory root fibre can be claimed appropriately, which makes it easier for consumers to make a conscious choice to support digestive health,” said Caroline Bustandi, senior manager of Regulatory Affairs at BENEO Asia Pacific. “This is especially key as close to a quarter of Indonesians found that the pandemic has made them more aware of their digestive health4. We will continue working to support food and drink manufacturers in Asia Pacific to formulate products and to communicate about their respective health benefits for the sake of the consumers in the region.”
Proven to improve well-being
Prebiotics are non-digestible fibres that impact the gut microbiota by selectively promoting the number of naturally-occurring good, beneficial bacteria in the intestine. A significant number of high-quality scientific studies5 have already established the efficacy of inulin and oligofructose in promoting the selective growth of beneficial bacteria in the colon, thereby supporting digestive health and overall wellbeing6.
Inulin and oligofructose are also the only scientifically proven plant-based prebiotics. In comparison to other fibres that are synthetically produced, they are obtained from a natural source – chicory root – via a gentle hot water extraction.
Additionally, both inulin and oligofructose belong to the few internationally recognised and confirmed prebiotics according to the International Scientific Association on Probiotics and Prebiotics7. An EU approved health claim granted for BENEO and inulin, for instance, has confirmed its beneficial effect on digestive health and regularity.
1 Deloitte Consumer Insights: Capturing Indonesia’s latent markets (2015)
2 FMCG Gurus Digestive Health Survey (2020)
3 FMCG Gurus Digestive Health Survey (2020)
4 FMCG Gurus COVID19 Survey Indonesia (Feb 2021)
5 So D, Whelan K, Rossi M et al. (2018) Dietary fiber intervention on gut microbiota composition in healthy adults: A systematic review and meta-analysis. Am J Clin Nutr 107(6): 965–983. https://www.ncbi.nlm.nih.gov/pubmed/29757343
6 Vandeputte D, Falony G, Vieira-Silva S, Wang J, Sailer M, Theis S, Verbeke K, Raes J. Prebiotic inulin-type fructans induce specific changes in the human gut microbiota. Gut. 2017 Nov 1;66(11):1968-74. Available from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5739857/
7 Gibson GR, Hutkins R, Sanders ME et al. (2017) Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nat Rev Gastroenterol Hepatol 14(8): 491–502. https://www.nature.com/articles/nrgastro.2017.75.pdf